Cognitive Bias Modification

Cognitive Bias Modification Intervention for Help-Seeking Stigma for Military Service Members at Elevated Suicide Risk

Waitlist Available
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
current active duty U.S. military service member
lifetime history of suicidal ideation per a self-report version of the SITBI-SF and/or current elevated suicide risk factors (i.e., screening positive for clinically significant suicidal ideation [DSI-SS Total Score > 2], depression [PHQ-9 Total Score > 14], anxiety [GAD-7 Total Score > 9], PTSD [PCL-5 Total Score > 32], alcohol use [AUDIT-C Total Score > 3 for men and > 2 for women], and/or anger [DARS Total Score > 22])
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up2-month follow-up
Awards & highlights

Study Summary

This trial will study how well a cognitive bias modification (CBM) intervention works to reduce stigma-related cognitions and improve behavioral health care utilization among military service members at risk for suicide.

Eligible Conditions
  • Military Service Members at Elevated Suicide Risk

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Client Satisfaction Questionnaire-8 (CSQ-8)
Intervention Acceptability and Feasibility Questionnaire
Perceived Stigma and Barriers to Care for Psychological Problems Scale (PS)
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Cognitive Bias Modification for Help-Seeking Stigma (CBM-HS)Experimental Treatment1 Intervention
CBM-HS is a 15-minute web-based intervention designed to alter maladaptive cognitions related to mental health help-seeking. In this task, individuals are presented with a series of statements regarding beliefs about using behavioral health services. Individuals then select "True" or "False" in response to each statement. Incorrect responses (i.e., demonstrating help-seeking stigma) are followed by corrective feedback. Conversely, correct responses (i.e., promoting help-seeking) are positively reinforced. Participants in this condition will complete three separate 15-minute CBM-HS sessions.
Group II: Self-Directed PsychoeducationActive Control1 Intervention
Participants randomized to this condition will review psychoeducation on mental health literacy, mental illness stigma, and treatment options. Readings will be compiled from resources available in the public domain. The duration will be comparable to the duration of study tasks for individuals in the CBM-HS study condition (i.e., three 15-minute sessions).
Group III: Placebo Cognitive Bias ModificationPlacebo Group1 Intervention
Participants randomized to this condition will complete a CBM task with a neutral stimuli. The duration of the CBM-Placebo task will be comparable to the duration of the CBM-HS task (i.e., three 15-minute sessions).
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Bias Modification Intervention for Help-Seeking Stigma

Find a site

Who is running the clinical trial?

Military Suicide Research ConsortiumOTHER
9 Previous Clinical Trials
1,825 Total Patients Enrolled
Florida State UniversityLead Sponsor
184 Previous Clinical Trials
29,605 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability for prospective participants in this clinical experiment?

"Per the information posted on, this experimental trial is actively searching for enrollees. This investigation was first announced in April 2020 and its latest update was published on April 4th 2022."

Answered by AI

How many individuals are being granted access to this clinical exploration?

"Affirmative. documents confirm that this investigation, which was first published on April 19th 2020, is actively recruiting participants. 308 individuals are needed from 2 distinct medical facilities to complete the trial."

Answered by AI
~36 spots leftby Sep 2024